Results 181 to 190 of about 3,780 (219)

L-Dopa codrugs containing antioxidant molecules as potential antiparkinson agents

2007
not ...
F. PINNEN, P. SOZIO, L. S. CERASA, A. IANNITELLI, I. CACCIATORE, A. COCCO, RICCIUTELLI, Massimo, GIORGIONI, Gianfabio, A. DI STEFANO   +8 more
openaire   +1 more source

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

An update on larynx cancer

Ca-A Cancer Journal for Clinicians, 2017
Kristin A Higgins, Nabil F Saba
exaly  

Nanooncology: The future of cancer diagnosis and therapy

Ca-A Cancer Journal for Clinicians, 2013
Sanjiv S Gambhir
exaly  

Novel isoxazole derivatives as potential antiparkinson agents: synthesis, evaluation of monoamine oxidase inhibitory activity and docking studies

, 2019
Neetu Agrawal, Pradeep Mishra
openalex   +1 more source

The current state of molecular testing in the treatment of patients with solid tumors, 2019

Ca-A Cancer Journal for Clinicians, 2019
Wafik S El-Deiry, Richard M Goldberg, Heinz-Josef Lenz   +2 more
exaly  

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

[Trends in drug therapy: Amantadine - application of an anti-influenza drug as an antiparkinson agent].

, 1976
Shuhei Murayama
openalex  

Biosynthesis of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), a possible antiparkinsonism agent.

, 1993
Yoshikazu Tasaki, Y. Makino, Shinji Ohta, Masaaki Hirobe   +3 more
openalex